Sphingosine phosphate lyase insufficiency syndrome (SPLIS) is a rare genetic condition caused by mutations in the SGPL1 gene. This gene encodes an essential enzyme needed to metabolize a group of ...

Meetings of the Grants Review Working Group will be held in a public session format except for the review of individual grant applications which will be conducted in closed session. THE ORDER OF ...

Les membres du public assistant à la réunion dans un lieu de téléconférence auront la possibilité de formuler des commentaires publics à chaque endroit, avec les mêmes limitations que celles imposées ...

El Instituto de Medicina Regenerativa de California y su Comité de Supervisión de Ciudadanos Independientes, y sus subcomités, cumplen con la Ley de Estadounidenses con Discapacidades (ADA, por sus ...

Objetivo de la investigación Proponemos un nuevo enfoque para la terapia de diferenciación para la leucemia mieloide aguda mediante la producción de un nivel local ...

Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. CIRM, ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

CIRM funds stem cell research to institutions throughout California. On the map below, click on any marker to learn more about our funding to that institution. You can explore the awards they’ve ...

本研究的目的是开发一种新的优化技术，通过神经元分化在培养皿中获得同质的中脑多巴胺能 (mDA) 神经元群体。 中脑的多巴胺能神经元是哺乳动物中枢神经系统中多巴胺的主要来源。 它们的 ...

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.